Robert Wallis is the Chief Science Officer at the Aurum Institute in Johannesburg, South Africa. He also holds adjunct appointments as Professor at Rutgers University, the Case Western Reserve University School of Medicine, and Vanderbilt University. Before joining Aurum, he served as the Therapeutic Area Clinical Lead for Infectious Diseases at Pfizer, where he led the clinical development of sutezolid.
